69.95
price down icon1.14%   -0.81
after-market Dopo l'orario di chiusura: 69.85 -0.10 -0.14%
loading

Astrazeneca PLC Borsa (AZN) Ultime notizie

pulisher
Jun 18, 2025

AstraZeneca (NASDAQ:AZN) PLC Stock Sees Institutional Growth on Nasdaq Composite - Kalkine Media

Jun 18, 2025
pulisher
Jun 18, 2025

AstraZeneca and GSK fall after Trump renews pharma tariff threat - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks drop and oil spikes as Iran 'will not surrender', AstraZeneca falls on tariff threat - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks drop into the red, AstraZeneca and GSK fall on Trump tariff threat - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

AstraZeneca, GSK shares down after Trump threatens drug import tariffs By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks edge higher as UK inflation eases, AstraZeneca and GSK fall - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks open higher as UK inflation eases, AstraZeneca and GSK fall - Proactive Investors

Jun 18, 2025
pulisher
Jun 17, 2025

Astrazeneca makes $5.3B drug R&D pact with CSPC - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 17, 2025

AstraZeneca (AZN) Faces Potential Changes in Drug Advertising Ru - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Levi & Korsinsky Reminds AstraZeneca PLC Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025AZN - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 15, 2025

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica

Jun 14, 2025
pulisher
Jun 13, 2025

Sector Update: Health Care Stocks Slide Late Afternoon - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Inks Up To $5.3B AI Drug Deal With Chinese Firm - Law360

Jun 13, 2025
pulisher
Jun 13, 2025

FIVE AT FIVE: FTSE 100 unsettled by Israel strike; AstraZeneca strikes $3.6bn Chinese AI deal - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca and CSPC partner on AI drug research By Investing.com - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca and CSPC partner on AI drug research - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal - Pharmaceutical Technology

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca, CSPC Pharmaceuticals Enter Research Agreement - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca signs research agreement with China's CSPC (AZN) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - BioPharma Dive

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Taps Into China’s R&D Engine With CSPC Alliance - insights.citeline.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 BillionAstraZeneca (NASDAQ:AZN) - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca, Chinese bio firm sign $5.2B drug deal - breakingthenews.net

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech - Financial Times

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Signs Nearly $5.3 Bln AI-enabled Research Deal With China's CSPC Pharma - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca (AZN) Enters Collaboration with CSPC for Novel Thera - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca: R&D agreement with CSPC Pharmaceuticals Group - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca bets big on AI and China with $3.6bn CSPC collaboration - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Enters Strategic Collaboration with CSPC Pharmaceuticals Group Limited - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca, CSPC Ink Strategic Research Collaboration for AI-Driven Drug Discovery - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

The Zacks Analyst Blog Highlights Microsoft, AstraZeneca and BlackRock, Taylor Devices and Geospace Technologies - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca partners with CSPC in deal worth up to $5.33 billion - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms $5.3 billion AI drug discovery deal with CSPC - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca signs AI research deal with China's CSPC for chronic diseases - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals - marketscreener.com

Jun 13, 2025
pulisher
Jun 12, 2025

Top Stock Reports for Microsoft, AstraZeneca & BlackRock - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Chancery Tags AstraZeneca Unit For $180M 'Expectation' Loss - Law360

Jun 12, 2025
pulisher
Jun 12, 2025

Leading bank sees AstraZeneca upside seen in hypertension drug, tempers lung cancer hopes - Proactive financial news

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca CFO Donates Shares to Charity - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca CFO donates shares to charity - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca CFO donates shares to charity By Investing.com - Investing.com UK

Jun 12, 2025
pulisher
Jun 12, 2025

REGAstraZeneca PLCDirector/PDMR Shareholding - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca (AZN): Vaccine Advisory Panel Reshuffled, Impact on Pharma Stocks | AZN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

UBS bullish on AstraZeneca’s baxdrostat, cautious on AVANZAR By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

At a bargain-basement valuation now, is AstraZeneca’s share price impossible for me to ignore? - Yahoo

Jun 12, 2025
pulisher
Jun 11, 2025

AstraZeneca (AZN) Watches CDC Vaccine Policy Developments | AZN Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1) - Bloomberg Law News

Jun 11, 2025
pulisher
Jun 11, 2025

AstraZeneca, Lilly & J&J: Strategic Moves Powering SGLT‐2 - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

AstraZeneca (AZN) Faces Competitive Pressure in Blood Pressure M - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

AstraZeneca (LSE:AZN) Partners In Quantum Leap For Drug Development Efficiency - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

AstraZeneca PLC (AZN) to Restructure U.S. Vaccine Advisory Committee Amid Trust Issues | AZN Stock - paginasiete.bo

Jun 10, 2025
pulisher
Jun 10, 2025

AstraZeneca (AZN) to Restructure U.S. Vaccine Advisory Committee Amid Trust Issues | AZN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

MORNING BID AMERICAS-White smoke or London fog? - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

AstraZeneca (AZN) Among Key Players in Pharmaceutical Sector | A - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

AstraZeneca PLC Being Investigated on Behalf of AstraZeneca PLC Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire

Jun 09, 2025
pulisher
Jun 09, 2025

AstraZeneca (AZN) Faces Challenges Amid Public Trust Crisis in Vaccines | AZN Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season - AOL.com

Jun 09, 2025
pulisher
Jun 09, 2025

AstraZeneca Pharma India names Praveen Rao Akkinepally as new MD, succeeding Dr Sanjeev Panchal - Medical Dialogues

Jun 09, 2025
pulisher
Jun 09, 2025

Quantum Computing Breakthrough: IonQ Slashes Drug Development Time From Months to Days - Stock Titan

Jun 09, 2025
Capitalizzazione:     |  Volume (24 ore):